SCHEMBL8313889

SCHEMBL8313889

CCOCCCSc1ccc(-c2ccnc(Nc3ccc(C(=O)N4CCN(C(=O)c5ccco5)CC4)cc3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 2/20 0.44
▸ CHUK O15111 2/20 0.44
▸ IKBKG Q9Y6K9 2/20 0.44
▸ HTT P42858 1/20 0.44
▸ JAK2 O60674 3/20 0.44
▸ GAA P10253 1/20 0.43
▸ TSHR P16473 4/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ LMNA P02545 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ CDK2 P24941 2/20 0.42
▸ CCNT1 O60563 1/20 0.42
▸ CCNA2 P20248 1/20 0.42
▸ CDK9 P50750 1/20 0.42
▸ CCNA1 P78396 1/20 0.42
▸ TP53 P04637 1/20 0.41
▸ ACVR1 Q04771 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ JAK3 P52333 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14021072 0.90 IKBKB (0.46) IKBKBCHUKIKBKGHTTJAK2
SCHEMBL4070513 0.89 IKBKB (0.48) IKBKBCHUKIKBKGHTTJAK2
SCHEMBL8308934 0.89 IKBKB (0.45) IKBKBCHUKIKBKGJAK2CDK2
SCHEMBL8308375 0.88 JAK2 (0.47) IKBKBCHUKIKBKGHTTJAK2
SCHEMBL8308363 0.87 IKBKB (0.50) IKBKBCHUKIKBKG
SCHEMBL14063857 0.86 IKBKB (0.49) IKBKBCHUKIKBKGHTTJAK2
SCHEMBL8315465 0.84 HTT (0.46) IKBKBCHUKIKBKGHTTJAK2
SCHEMBL8309514 0.83 JAK2 (0.45) IKBKBCHUKIKBKGJAK2ALDH1A1
SCHEMBL14021618 0.82 HTT (0.54) IKBKBCHUKIKBKGHTTJAK2
SCHEMBL14021252 0.81 ALDH1A1 (0.62) IKBKBCHUKIKBKGHTTJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 — — WO disclosed
Send feedback